A 62-year-old man with nonischemic
cardiomyopathy, a history of Boston Scientific biventricular implantable
cardioverter-defibrillator placement (in 2011), ventricular tachycardia after
radiofrequency ablation (April and November 2014), paroxysmal atrial
fibrillation, and severe mitral regurgitation presented with acute exacerbation
of heart failure. A resting electrocardiogram (ECG) showed normal sequential
atrioventricular (AV) pacing at a heart rate of 63 beats/min. Baseline device
settings were DDD with a lower rate of 60 beats/min, an upper rate of 115 beats/min,
a minimum sensed AV delay of 135 ms, and a minimum paced AV delay of 180 ms.
The patient underwent mitral valve replacement. Three days later, the pacemaker
rate was increased to 80 beats/min, and an ECG showed pacing concomitantly within
the T wave in beats 5 and 13 of the rhythm strip (Fig. 1).
Should pacemaker malfunction be suspected?
Answer
The ECG is
compatible with normal function of the device. Biventricular pacemakers
frequently have features that attempt to promote pacing and thus ventricular resynchronization.
Ventricular sense response resynchronizes ventricular depolarization upon
frequent changes in R-R intervals, particularly in patients with atrial fibrillation
or frequent premature ventricular contractions (PVCs). On a surface ECG, these
events appear as pacing stimuli within a native ventricular depolarization during
the attempt to resynchronize the ventricle. This can lead to fusion or
pseudofusion beats, depending on the effect of pacing on the depolarization. Typically,
these resynchronization stimuli occur 1.25 ms after the initial ventricular
stimulus and would not be expected during the T wave.1
In this ECG, the
AV delay is near the programmed minimum at 200 ms in sequentially paced beats
(as shown on beat 2). On beat 3, an atrial stimulus and a PVC appear to inhibit
further pacer output. On beat 5, an atrial stimulus and PVC appear almost
simultaneously. A pacemaker stimulus follows, notably after a 200-ms delay.
This suggests that the PVC occurred during the device’s ventricular blanking
period, during which the ventricular lead is “blinded” to native ventricular depolarization
and thus continues programmed pacing. Therefore, an appropriate 2nd stimulus
attempts to pace the ventricle. Pacing stimuli on a T wave can theoretically
produce ventricular tachycardia or fibrillation and should prompt device
evaluation.2,3
In many devices,
when a PVC occurs immediately after the post-atrial ventricular blanking (PAVB)
period, the PVC usually falls within the crosstalk zone and leads to
ventricular-safety pacing. This sequence is initiated after an atrial-paced
stimulus, after which comes a sensed event in the ventricular channel. The AV
delay of the safety-paced beat is usually much shorter than the programmed AV
delay. However, on beat 2 of our patient’s ECG, the expected safety pacing was
absent, because this manufacturer’s pacing algorithm does not use a crosstalk
zone for safety pacing. There is only a programmable PAVB period, selected
manually (range, 30–200 ms).
Of note, PVCs
occurred in a similar manner in our patient, after which a 2nd pacemaker
stimulus did not occur on the T wave. Upon review of the timing and morphology
of each PVC, ECG beats 3, 7, and 11 had a similar morphology: negative
deflection in lead aVL, positive deflection in leads II through aVF, and an
early R wave in lead V1. This suggests a left lateral location—spatially the
farthest from the RV lead, allowing delayed arrival outside the blanking period
of the RV lead and thus inhibiting stimuli output. The remaining PVCs, in
contrast, appear to have had a positive deflection in lead aVL and a negative
deflection in leads II through aVF, suggesting an inferoapical left ventricular
location much closer to the RV lead. Earlier transit might have caused the
inferoapical PVCs to fall within the device’s blanking period and led to the
discharge seen on the T wave. The exception is beat 9, on which the PVC appears
to have occurred about 40 ms later (after the atrial stimuli) than on beats 5
and 13—allowing the signal to fall outside the blanking period and leading to
inhibited ventricular-stimulus output.
In this patient, device interrogation
showed normal function, no undersensing episodes, and stable lead impedances. No
atrial fibrillation or high ventricular rates were recorded. Postoperatively,
amiodarone was started, and no further pacemaker stimuli were seen within the T
wave.
References
1. Lloyd MS, El
Chami MF, Langberg JJ. Pacing features that mimic malfunction: a review of
programmable and automated device functions that cause confusion in the
clinical setting. J Cardiovasc Electrophysiol 2009;20(4):453-60.
2. Love CJ. Pacemaker
troubleshooting and follow-up. In: Ellenbogen KA, Kay GN, Lau CP, Wilkoff BL,
editors. Clinical cardiac pacing defibrillation and resynchronization therapy. 3rd
ed. Philadelphia: Elsevier; 2007. p. 1005-62.
3. Conover MB. Understanding
electrocardiography. 8th ed. St. Louis: Mosby; 2002. p. 245.
Comments have closed.
No comments:
New comments are not allowed.